Total net revenue of $15.2 millionAdjusted EBITDA1 of $(0.8) million, which includes EXXUA launch investments$30.0 million cash balance at December 31, 2025Company launched EXXUA™ (gepirone) ...

Total net revenue of $15.2 millionAdjusted EBITDA1 of $(0.8) million, which includes EXXUA launch investments$30.0 million cash balance at December 31, 2025Company launched EXXUA (gepirone) extended-r ...

As consumers, we all sense the shift. Digital content has moved us into a world dominated by subscriptions and cloud‑based access, where we own ...

I'm a busy mom, and it’s not easy to find time for my mental health, so I tried online group and family therapy with Grouport ...

Matthew Burgess, director of View Legal, said overall TD2026/D1 is a helpful summary of key rules in this area but in ...

Meeting with the FDA to review the results from the Phase 3 EFZO-FIT™ study and determine the path forward for efzofitimod in pulmonary sarcoidosis is scheduled for mid-April 2026.

This moment of revelation is common to many people who don’t form mental images. They report that they might never have ...

Newron Pharmaceuticals S.p.A. ("Newron") (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on developing novel ...

ARKO Corp. (Nasdaq: ARKO) ('ARKO” or the 'Company”), a Fortune 500 company and one of the largest convenience store operators in the United States, today announced preliminary estimated financial ...

Minnesota shows what’s possible—here’s how we turn that spark into the kind of disruptive power that can actually stop ICE ...

As African mines go deeper and rainfall patterns grow increasingly unpredictable, dewatering has moved beyond being a support function to become a strategic discipline. The choice between ...

For Black folks, masked men with guns, arbitrary detention, children seized, bodies made disposable, and law operating as ...